OcuTerra taps new CFO

OcuTerra, a clinical stage ophthalmology pharmaceutical company, has named Bill Steinkrauss as its new CFO. 

Mr. Steinkrauss is the founder of OWL CFO Consulting, a consulting firm providing part-time CFO services to companies in the biotechnology industry. He previously served as CFO and chief administrative officer of Curis, a publicly traded biotechnology company.

In his new role, Mr. Steinkrauss will lead financial strategy and operations as OcuTerra advances its lead asset for the treatment of diabetic retinopathy, OTT166. 

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast